Advanced Solid Malignancies clinical trials

Explore recruiting advanced solid malignancies clinical trials.

Recruiting advanced solid malignancies studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Solid Malignancies trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2a, Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of BMS-986523 as Monotherapy and in Combination with Anti-cancer Agents in Participants with Advanced Solid Malignancies

Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

An Open-label Study to check Safety, Tolerability and medication behaviour of a capsule with AZD6244 in Patients with Advanced Solid Malignancies

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

A trial to learn how saruparib works and how safe it is in the bodies of adults with advanced solid tumors

Bulgaria, Romania

Human Pharmacology (Phase I)- Other EU CTIS Study details

PHASE 1/2 STUDY OF PARG INHIBITOR ETX-19477 IN PATIENTS WITH ADVANCED SOLID MALIGNANCIES

Spain, France, Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Study of NTX-1088 as Monotherapy and Combined with Pembrolizumab

Poland

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Modular Phase I/IIa, Open-label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Ascending Doses of AZD5305 as Monotherapy and in Combination with Anti-cancer Agents in Patients with Advanced Solid Malignancies (PETRA)

Spain, Poland, Italy, Czechia, Hungary

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Advanced Solid Malignancies trials by city

Advanced Solid Malignancies in Toronto Advanced Solid Malignancies in Vancouver Advanced Solid Malignancies in Montreal Advanced Solid Malignancies in Calgary Advanced Solid Malignancies in Edmonton Advanced Solid Malignancies in Ottawa Advanced Solid Malignancies in Winnipeg Advanced Solid Malignancies in Quebec City Advanced Solid Malignancies in Hamilton Advanced Solid Malignancies in Kitchener Advanced Solid Malignancies in London Advanced Solid Malignancies in Halifax Advanced Solid Malignancies in New York Advanced Solid Malignancies in Los Angeles Advanced Solid Malignancies in Chicago Advanced Solid Malignancies in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease